Download
Download by
Scanning QR Code
  • Download app

    Download app

  • Online Inquiry

    Log in to access Online Inquiry
+
Congratulations
You've successfully got advanced quotes worth 5000 HKD
Download APP >>
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Futubull > Quotes > SCLX Scilex Holding > Detailed Quotes

SCLX Scilex Holding

Watchlist
7.000
-0.890-11.28%
Close  02/01 16:00 ET
6.890
-0.110-1.57%
Post Mkt Price 02/01 19:53 ET
High
7.850
Open
7.710
Turnover
4.01M
Low
6.330
Pre Close
7.890
Volume
589.68K
Market Cap
989.44M
P/E(TTM)
Loss
52wk High
11.690
Shares
141.35M
P/E(Static)
Loss
52wk Low
2.870
Float Cap
39.36M
Bid/Ask %
96.08%
Historical High
11.690
Shs Float
5.62M
Volume Ratio
0.97
Historical Low
2.870
Dividend TTM
--
Div Yield TTM
--
P/B
24.56
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
10.49%
Amplitude
19.27%
Avg Price
6.791
Lot Size
1
Float Cap
39.36M
Bid/Ask %
96.08%
Historical High
11.690
Shs Float
5.62M
Volume Ratio
0.97
Historical Low
2.870
Dividend TTM
--
P/B
24.56
Dividend LFY
--
Turnover Ratio
10.49%
Amplitude
19.27%
Avg Price
6.791
Lot Size
1
Price Forecast

News

Comment

Company Overview More
Scilex Holding Co. engages in the acquisition, development, and commercialization of non-opioid pain management products for the treatment of acute and chronic pain. Its products include ZTlido, a prescription lidocaine topical product approved by the FDA for the relief of neuropathic pain associated with PHN, which is a form of post-shingles nerve pain, and e GLOPERBA oral solutions, an FDA-approved prophylactic treatment for painful gout flares in adults. The company was founded on February 21, 2020 and is headquartered in Palo Alto, CA.
CEO: Mr. Jaisim Shah
Market: NASDAQ
Listing Date: 01/07/2021
Futu Hot List
USHKCN
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist